Angiotensin II and TGF-β1 Induce Alterations in Human Amniotic Fluid-Derived Mesenchymal Stem Cells Leading to Cardiomyogenic Differentiation Initiation

BACKGROUND AND OBJECTIVES: Human amniotic fluid-derived mesenchymal stem cells (AF-MSCs) may be a valuable source for cardiovascular tissue engineering and cell therapy. The aim of this study is to verify angiotensin II and transforming growth factor-beta 1 (TGF-β1) as potential cardiomyogenic diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasiūnienė, Monika, Petkus, Gintautas, Matuzevičius, Dalius, Navakauskas, Dalius, Navakauskienė, Rūta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Stem Cell Research 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657950/
https://www.ncbi.nlm.nih.gov/pubmed/31023001
http://dx.doi.org/10.15283/ijsc18126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657950/
https://www.ncbi.nlm.nih.gov/pubmed/31023001
http://dx.doi.org/10.15283/ijsc18126

Ejemplares similares